{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:32:15Z","timestamp":1740184335347,"version":"3.37.3"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["UH2CA267502"],"award-info":[{"award-number":["UH2CA267502"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE034056","R01DE027185","K99\/R00DE030194"],"award-info":[{"award-number":["R01DE034056","R01DE027185","K99\/R00DE030194"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.tvr.2024.200295","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T23:58:17Z","timestamp":1730505497000},"page":"200295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The imprint of viral oncoproteins on the variable clinical behavior among human papilloma virus-related oropharyngeal squamous cell carcinomas"],"prefix":"10.1016","volume":"18","author":[{"given":"Malay K.","family":"Sannigrahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovely","family":"Raghav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6626-7013","authenticated-orcid":false,"given":"Ahmed","family":"Diab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devraj","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvr.2024.200295_bib1","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.ajpath.2021.06.012","article-title":"Myeloid cells are enriched in tonsillar crypts, providing insight into the viral tropism of human papillomavirus","volume":"191","author":"Mattox","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"Pt 1","key":"10.1016\/j.tvr.2024.200295_bib2","first-page":"111","article-title":"The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance","volume":"185","author":"Perry","year":"1994","journal-title":"J. Anat."},{"key":"10.1016\/j.tvr.2024.200295_bib3","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0289","article-title":"Modelling human papillomavirus biology in oropharyngeal keratinocytes","volume":"374","author":"Roberts","year":"2019","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.tvr.2024.200295_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41388-023-02927-9","article-title":"HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions","volume":"43","author":"Lim","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.tvr.2024.200295_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/oncolo\/oyae071","article-title":"Human malignancies associated with persistent HPV infection","volume":"29","author":"McBride","year":"2024","journal-title":"Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29461","article-title":"The human papillomavirus late life cycle and links to keratinocyte differentiation","volume":"96","author":"Kirk","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53","volume":"529","author":"Martinez-Zapien","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tvr.2024.200295_bib10","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/JVI.75.12.5559-5566.2001","article-title":"Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites","volume":"75","author":"Oh","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2013.04.026","article-title":"Papillomavirus E6 oncoproteins","volume":"445","author":"Vande Pol","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib12","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.3390\/v7072785","article-title":"The human papillomavirus E6 PDZ binding motif: from life cycle to malignancy","volume":"7","author":"Ganti","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.tvr.2024.200295_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01737-17","article-title":"The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 to suppress RIG-I-mediated innate immune signaling","volume":"92","author":"Chiang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib14","doi-asserted-by":"crossref","first-page":"9737","DOI":"10.1128\/JVI.00881-07","article-title":"Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor","volume":"81","author":"Huh","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib15","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1073\/pnas.1819534116","article-title":"PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis","volume":"116","author":"Hatterschide","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tvr.2024.200295_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","article-title":"The papillomavirus E7 proteins","volume":"445","author":"Roman","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01812-19","article-title":"Human papillomavirus E7 oncoprotein subverts host innate immunity via SUV39H1-mediated epigenetic silencing of immune sensor genes","volume":"94","author":"Lo Cigno","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib18","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI129497","article-title":"HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING","volume":"130","author":"Luo","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tvr.2024.200295_bib19","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/jvi.67.8.4521-4532.1993","article-title":"The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes","volume":"67","author":"Straight","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","article-title":"The E5 proteins","volume":"445","author":"DiMaio","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.20558","article-title":"E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I","volume":"113","author":"Ashrafi","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tvr.2024.200295_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112508","article-title":"Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway","volume":"42","author":"Miyauchi","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tvr.2024.200295_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2013.07.020","article-title":"The E1 proteins","volume":"445","author":"Bergvall","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virol.2013.06.006","article-title":"The papillomavirus E2 proteins","volume":"445","author":"McBride","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","article-title":"The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tvr.2024.200295_bib26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tvr.2024.200295_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216532120","article-title":"Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors","volume":"120","author":"Schrank","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tvr.2024.200295_bib28","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-20-4789","article-title":"Recurrent human papillomavirus-related head and neck cancer undergoes metabolic reprogramming and is driven by oxidative phosphorylation","volume":"27","author":"Vyas","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tvr.2024.200295_bib29","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib30","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.hoc.2021.05.004","article-title":"Cancer of the oropharynx and the association with human papillomavirus","volume":"35","author":"Rettig","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.tvr.2024.200295_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","article-title":"The changing therapeutic landscape of head and neck cancer","volume":"16","author":"Cramer","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaoncol.2016.3067","article-title":"Differences in the prevalence of human papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method","volume":"3","author":"D'Souza","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib34","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/cncr.31385","article-title":"Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults","volume":"124","author":"Windon","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.tvr.2024.200295_bib35","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1200\/JCO.19.00370","article-title":"Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals","volume":"37","author":"Tota","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib36","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","article-title":"Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy","volume":"26","author":"Langendijk","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/15384047.2015.1108489","article-title":"E6 viral protein ratio correlates with outcomes in human papillomavirus related oropharyngeal cancer","volume":"17","author":"Hong","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tvr.2024.200295_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcv.2014.06.019","article-title":"Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer","volume":"61","author":"Um","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib39","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.oraloncology.2015.09.007","article-title":"Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters","volume":"51","author":"Ramqvist","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124762","article-title":"Variations in HPV function are associated with survival in squamous cell carcinoma","volume":"4","author":"Gleber-Netto","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.tvr.2024.200295_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159600","article-title":"HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1\u03b1\/ERR\u03b1 axis","volume":"7","author":"Sannigrahi","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.tvr.2024.200295_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tibs.2014.10.010","article-title":"The utility of protein and mRNA correlation","volume":"40","author":"Payne","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tvr.2024.200295_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02068-14","article-title":"E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78","volume":"6","author":"Ajiro","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.tvr.2024.200295_bib44","doi-asserted-by":"crossref","first-page":"D499","DOI":"10.1093\/nar\/gkw879","article-title":"The Papillomavirus Episteme: a major update to the papillomavirus sequence database","volume":"45","author":"Van Doorslaer","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tvr.2024.200295_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020366","article-title":"Splicing and polyadenylation of human papillomavirus type 16 mRNAs","volume":"18","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tvr.2024.200295_bib46","first-page":"13","article-title":"Causes and consequences of HPV integration in head and neck squamous cell carcinomas: state of the art","author":"Balaji","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tvr.2024.200295_bib47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.virol.2006.10.012","article-title":"Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells","volume":"360","author":"Milligan","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib48","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.celrep.2018.10.007","article-title":"Genomic and transcriptomic characterization links cell lines with aggressive head and neck cancers","volume":"25","author":"Cheng","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tvr.2024.200295_bib49","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21174","article-title":"Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines","volume":"8","author":"Kalu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tvr.2024.200295_bib50","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.18632\/oncotarget.8254","article-title":"Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis","volume":"7","author":"Vermeer","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tvr.2024.200295_bib51","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.celrep.2019.10.005","article-title":"An immunocompetent mouse model of HPV16(+) head and neck squamous cell carcinoma","volume":"29","author":"Carper","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.tvr.2024.200295_bib52","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1002\/ijc.33125","article-title":"Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models","volume":"147","author":"Facompre","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tvr.2024.200295_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191581","article-title":"Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma","volume":"13","author":"Anayannis","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tvr.2024.200295_bib54","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1038\/s41388-020-01431-8","article-title":"E4, E5 drive alternative carcinogenic pathways in HPV positive cancers","volume":"39","author":"Ren","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.tvr.2024.200295_bib55","first-page":"5916","article-title":"Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites","volume":"60","author":"Thorland","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.tvr.2024.200295_bib56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gcc.2870050209","article-title":"Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines","volume":"5","author":"Smith","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.tvr.2024.200295_bib57","doi-asserted-by":"crossref","first-page":"15544","DOI":"10.1073\/pnas.1416074111","article-title":"Genome Atlas, Characterization of HPV and host genome interactions in primary head and neck cancers","volume":"111","author":"Parfenov","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tvr.2024.200295_bib58","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/1878-0261.13219","article-title":"Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma","volume":"16","author":"Mainguen\u00e9","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41525-021-00264-y","article-title":"Recurrent integration of human papillomavirus genomes at transcriptional regulatory hubs","volume":"6","author":"Warburton","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.tvr.2024.200295_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.meegid.2018.03.003","article-title":"Understanding the HPV integration and its progression to cervical cancer","volume":"61","author":"Oyervides-Mu\u00f1oz","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.tvr.2024.200295_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/jmedgenet-2018-105745","article-title":"Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning","volume":"56","author":"Huang","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tvr.2024.200295_bib62","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.18632\/oncotarget.15179","article-title":"Analysis of the Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma","volume":"8","author":"Nulton","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tvr.2024.200295_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.0.CO;2-#","article-title":"Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer","volume":"74","author":"Vernon","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"Pt 10","key":"10.1016\/j.tvr.2024.200295_bib64","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1099\/0022-1317-76-10-2589","article-title":"Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR","volume":"76","author":"Daniel","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006211","article-title":"The role of integration in oncogenic progression of HPV-associated cancers","volume":"13","author":"McBride","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tvr.2024.200295_bib66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0042-6822(87)90195-4","article-title":"Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6\/E7 open reading frames","volume":"161","author":"Choo","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib67","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-16-0323","article-title":"Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tvr.2024.200295_bib68","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.oraloncology.2018.03.015","article-title":"Patients with integrated HPV16 in head and neck cancer show poor survival","volume":"80","author":"Nulton","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1541-7786.MCR-17-0153","article-title":"HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers","volume":"16","author":"Koneva","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.tvr.2024.200295_bib70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hed.26501","article-title":"Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma","volume":"43","author":"Pinatti","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.tvr.2024.200295_bib71","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hed.24429","article-title":"Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma","volume":"38","author":"Lim","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.tvr.2024.200295_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088718","article-title":"Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression","volume":"9","author":"Olthof","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tvr.2024.200295_bib73","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ijc.29712","article-title":"Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis","volume":"138","author":"Vojtechova","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tvr.2024.200295_bib74","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2159-8290.CD-22-0900","article-title":"Intratumoral heterogeneity and clonal evolution induced by HPV integration","volume":"13","author":"Akagi","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tvr.2024.200295_bib75","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1158\/1078-0432.CCR-21-2484","article-title":"Extrachromosomal DNA in HPV-mediated oropharyngeal cancer drives diverse oncogene transcription","volume":"27","author":"Pang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tvr.2024.200295_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1264646","article-title":"Long-read sequencing of oropharyngeal squamous cell carcinoma tumors reveal diverse patterns of high-risk Human Papillomavirus integration","volume":"13","author":"Gauthier","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00729-24","article-title":"HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer","volume":"15","author":"Yu","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.tvr.2024.200295_bib78","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1128\/JVI.00483-12","article-title":"Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR","volume":"86","author":"Cornet","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib79","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1128\/JVI.79.11.7014-7023.2005","article-title":"Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib81","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12105-021-01318-4","article-title":"Oropharyngeal squamous cell carcinoma morphology and subtypes by human papillomavirus type and by 16 lineages and sublineages","volume":"15","author":"Lewis","year":"2021","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.tvr.2024.200295_bib82","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.annonc.2022.03.005","article-title":"Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis","volume":"33","author":"Lang Kuhs","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tvr.2024.200295_bib83","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/jmv.20978","article-title":"Activities of human papillomavirus 16 E6 natural variants in human keratinocytes","volume":"79","author":"Asadurian","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib84","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.meegid.2008.07.002","article-title":"Detecting recombination and diversifying selection in human alpha-papillomavirus","volume":"8","author":"Carvajal-Rodr\u00edguez","year":"2008","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.tvr.2024.200295_bib85","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00239-002-2344-y","article-title":"Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes","volume":"55","author":"DeFilippis","year":"2002","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.tvr.2024.200295_bib86","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virol.2006.01.038","article-title":"HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6","volume":"350","author":"Lichtig","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib87","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1128\/JVI.78.11.5934-5945.2004","article-title":"Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras","volume":"78","author":"Chakrabarti","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200295_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2008.09.036","article-title":"Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis","volume":"383","author":"Zehbe","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200295_bib89","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1039\/D3SC02782A","article-title":"Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6","volume":"14","author":"Ye","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.tvr.2024.200295_bib90","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.chembiol.2012.03.007","article-title":"Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins","volume":"19","author":"Fera","year":"2012","journal-title":"Chem. Biol."},{"doi-asserted-by":"crossref","unstructured":"C.Y. Zhao, L. Szekely, W. Bao, G. Selivanova, Rescue of p53 function by small-molecule RITA in cervical carcinoma by blocking E6-mediated degradation, Cancer Res., 70 3372-3381.","key":"10.1016\/j.tvr.2024.200295_bib91","DOI":"10.1158\/0008-5472.CAN-09-2787"},{"key":"10.1016\/j.tvr.2024.200295_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tvr.2024.200295_bib93","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.1295005","article-title":"Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation","volume":"19","author":"Teyssier","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.tvr.2024.200295_bib94","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.celrep.2015.12.043","article-title":"Deposition of 5-methylcytosine on enhancer RNAs enables the coactivator function of PGC-1\u03b1","volume":"14","author":"Aguilo","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.tvr.2024.200295_bib95","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/onc.2011.415","article-title":"The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription","volume":"31","author":"Hsu","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.tvr.2024.200295_bib96","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3892\/ol.2020.12423","article-title":"PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma","volume":"21","author":"Matsubara","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tvr.2024.200295_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110417","article-title":"A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer","volume":"38","author":"Tang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tvr.2024.200295_bib98","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tvr.2024.200295_bib99","article-title":"Histone H3K4 methyltransferases as targets for drug-resistant cancers","volume":"10","author":"Yang","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.tvr.2024.200295_bib100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7150\/jca.57663","article-title":"Oncogene or tumor suppressor: the coordinative role of lysine methyltransferase SET7\/9 in cancer development and the related mechanisms","volume":"13","author":"Gu","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.tvr.2024.200295_bib101","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1016\/j.celrep.2019.05.066","article-title":"Inhibition of ERR\u03b1 prevents mitochondrial pyruvate uptake exposing NADPH-generating pathways as targetable vulnerabilities in breast cancer","volume":"27","author":"Park","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.tvr.2024.200295_bib102","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1101\/gad.330746.119","article-title":"Estrogen-related receptors are targetable ROS sensors","volume":"34","author":"Vernier","year":"2020","journal-title":"Genes Dev."}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679024000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679024000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T02:38:01Z","timestamp":1737427081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679024000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":102,"alternative-id":["S2666679024000193"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2024.200295","relation":{},"ISSN":["2666-6790"],"issn-type":[{"type":"print","value":"2666-6790"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The imprint of viral oncoproteins on the variable clinical behavior among human papilloma virus-related oropharyngeal squamous cell carcinomas","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2024.200295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200295"}}